Oracle Investment Management as of Dec. 31, 2024
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 19 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 42.8 | $79M | 1.0M | 76.86 | |
| Biohaven (BHVN) | 17.3 | $32M | 852k | 37.35 | |
| Select Sector Spdr Tr Put Put Option | 8.6 | $16M | 115k | 137.57 | |
| Ardelyx (ARDX) | 5.8 | $11M | 2.1M | 5.07 | |
| Springworks Therapeutics (SWTX) | 5.0 | $9.2M | 255k | 36.13 | |
| Biohaven Call Call Option | 4.1 | $7.5M | 200k | 37.35 | |
| Quidel Corp (QDEL) | 2.9 | $5.3M | 118k | 44.55 | |
| BioCryst Pharmaceuticals (BCRX) | 2.2 | $4.0M | 536k | 7.52 | |
| Novavax Call Call Option | 2.0 | $3.7M | 466k | 8.04 | |
| Ardelyx Call Call Option | 1.6 | $3.0M | 585k | 5.07 | |
| Forian Ord (FORA) | 1.5 | $2.8M | 1.4M | 2.06 | |
| Teladoc Health Call Call Option | 1.5 | $2.7M | 298k | 9.09 | |
| Palantir Technologies Cl A (PLTR) | 1.2 | $2.2M | 29k | 75.63 | |
| Cava Group Ord (CAVA) | 1.1 | $2.1M | 19k | 112.80 | |
| Springworks Therapeutics Call Call Option | 1.1 | $2.0M | 56k | 36.13 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $1.2M | 145k | 8.12 | |
| Pacific Biosciences of California (PACB) | 0.3 | $512k | 280k | 1.83 | |
| Biogen Idec (BIIB) | 0.2 | $369k | 2.4k | 152.92 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.1 | $242k | 33k | 7.45 |
